Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis bcl 2 family'

Search results for: 'research area apoptosis bcl 2 family'

Items 31-40 of 65

Page
per page
  1. Sunitinib malate
    A8255 Sunitinib malate
     2 Citation
    Target: VEGFR
    Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
      ≥26.65 mg/mL
  2. AZD2932
    B5835 AZD2932
    Target: FLT3|VEGFR|PDGFR|c-Kit
    Summary: inhibitor of VEGFR-2, PDGFRβ, Flt-3, and c-Kit
      Soluble in DMSO
  3. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL
  4. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR inhibitor
      ≥21.35 mg/mL
  5. Dovitinib (TKI-258, CHIR-258)
    A2168 Dovitinib (TKI-258, CHIR-258)
     2 Citation
    Target: FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Multitargeted RTK inhibitor
      insoluble in H2O; insoluble in EtOH; ≥36.35 mg/mL
  6. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: C-Met inhibitor, potent and selective
      ≥25.65 mg/mL
  7. Cediranib (AZD217)
    A1882 Cediranib (AZD217)
    Target: VEGFR
    Summary: VEGFR inhibitor receptor,highly potent
      ≥22.52 mg/mL
  8. BLZ945
    B4899 BLZ945
     1 Citation
    Target: CSF-1R
    Summary: CSF-1R kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.9 mg/mL
  9. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  10. BMS-794833
    B1438 BMS-794833
    Target: MET|Flk-1
    Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive
      ≥23.45 mg/mL

Items 31-40 of 65

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 2item
  2. Axl 1 item
  3. ALK 2item
  4. c-FMS 1 item
  5. c-Kit 1 item
  6. c-MET 7item
  7. c-RET 4item
  8. CSF-1R 1 item
  9. EGFR 12item
  10. FAK 3item
  11. FGFR 5item
  12. FLT3 1 item
  13. HER2 5item
  14. IGF1R 1 item
  15. LRRK2 4item
  16. PDGFR 6item
  17. Pyk2 2item
  18. Spleen Tyrosine Kinase (Syk) 1 item
  19. Src 4item
  20. Tie-2 2item
  21. Trk 1 item
  22. VEGFR 21item
Specificity
  1. Selective 48item
Reversibility
  1. Reversible 7item
  2. Irreversible 4item
Target
  1. Raf 5item
  2. Aurora Kinases 1 item
  3. CSF-1R 1 item
  4. FLT3 4item
  5. Eph Receptors 1 item
  6. VEGFR 27item
  7. PDGFR 8item
  8. c-Kit 6item
  9. RET 2item
  10. Bcr-Abl 1 item
  11. FGFR 7item
  12. MET 4item
  13. Src 3item
  14. Trk Receptors 2item
  15. EGFR 11item
  16. FAK 3item
  17. BMP and Other Activin Receptors 1 item
  18. JAK 1 item
  19. Syk 1 item
  20. ErbB 2item
  21. c-MET 2item
  22. HER2 1 item
  23. Pyk2 3item
  24. LRRK2 4item
  25. Insulin and Insulin-like Receptors 2item
  26. ALK 1 item
  27. Tie-2 3item
  28. ZAP-70 1 item
  29. Flk-1 1 item
  30. c-RET 1 item
  31. KDR 1 item
  32. Fyn kinase 1 item
  33. c-Fms tyrosine kinase 1 item
  34. Lyn kinase 1 item
  35. ErbB-2 1 item
  36. DCLK2 1 item
  37. Flk1 1 item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 3item
  6. Bladder Carcinoma 1 item
  7. Breast Cancer 14item
  8. Cancer 49item
  9. Cholangiocarcinoma 1 item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Clear Cell Renal Cell Carcinoma 1 item
  12. Colon Cancer 3item
  13. Colon Carcinoma 1 item
  14. Colorectal Cancer 9item
  15. Glioblastoma 3item
  16. Glioma 2item
  17. Hepatocellular Carcinoma 2item
  18. Liver Cancer 2item
  19. Lung Cancer 5item
  20. Lung Carcinoma 1 item
  21. Lymphoma 1 item
  22. Melanoma 1 item
  23. Multiple Myeloma 3item
  24. Non-small Cell Lung Cancer 3item
  25. Ovarian Cancer 4item
  26. Pancreatic Cancer 7item
  27. Prostate Cancer 5item
  28. Renal Cancer 2item
  29. Renal Cell Carcinoma 3item
  30. Thyroid Cancer 3item